Aura Biosciences (AURA) Change in Account Payables (2020 - 2026)

Aura Biosciences (AURA) has 7 years of Change in Account Payables data on file, last reported at $1.0 million in Q1 2026.

• Quarterly Change in Account Payables rose 443.62% year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $476000.0 (up 195.65% YoY) and the FY2025 annual result came in at -$846000.0, down 275.52% from the prior year.
• Change in Account Payables rose to $1.0 million in Q1 2026, from -$430000.0 in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $1.0 million in Q1 2026 to a low of -$1.9 million in Q1 2023.
• A 5-year average of -$2352.9 and a median of $23000.0 in 2024 frame the typical range for Change in Account Payables.
• Annual changes were most pronounced in 2022 — Change in Account Payables jumped 524.54% — and 2025, when it plunged 1395.65%.
• Tracing AURA's Change in Account Payables over 5 years: stood at $1.0 million in 2022, then slumped by 55.11% to $457000.0 in 2023, then sank by 32.17% to $310000.0 in 2024, then tumbled by 238.71% to -$430000.0 in 2025, then soared by 338.14% to $1.0 million in 2026.
• The last three Change in Account Payables figures came in at $1.0 million (Q1 2026), -$430000.0 (Q4 2025), and $602000.0 (Q3 2025), per Business Quant data.